Data / Research funding / Illinois / Dupage Medical Technology, Inc.
Dupage Medical Technology, Inc.: 3 NIH awards ($4.3M), fiscal years 2021 to 2026
Dupage Medical Technology, Inc. in Chicago, IL is funded under 3 NIH awards ($4.3M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- PBQ3ANGJVJ15
- State
- Illinois
Awards
3 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| Developing a new drug for treating myocardial ischemia/reperfusion injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,998,610 | September 20, 2021 | August 31, 2025 | SKIDGEL, RANDAL A | reporter.nih.gov |
| Targeting integrin outside-in signaling for treating sepsis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,993,937 | September 1, 2018 | May 31, 2025 | SKIDGEL, RANDAL A | reporter.nih.gov |
| A new drug to treat transplant-associated renal ischemia-reperfusion injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $306,867 | August 1, 2025 | July 31, 2027 | SKIDGEL, RANDAL A | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2025 | 1 | $306,867 | 0 | $0 |
| 2023 | 1 | $582,071 | 0 | $0 |
| 2022 | 2 | $1,776,688 | 0 | $0 |
| 2021 | 2 | $1,633,788 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required) | RFA-DK-27-125 | NIH | 93.847 | November 6, 2026 | Not listed | Same assistance listing 93.847 as 1 award here |
| Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) | RFA-DK-27-112 | NIH | 93.847 | November 9, 2026 | Not listed | Same assistance listing 93.847 as 1 award here |
| Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required) | RFA-DK-27-139 | NIH | 93.847 | November 9, 2026 | Not listed | Same assistance listing 93.847 as 1 award here |
| Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) | RFA-DK-27-122 | NIH | 93.847 | November 17, 2026 | Not listed | Same assistance listing 93.847 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.839 | December 3, 2026 | Not listed | Same assistance listing 93.839 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.839 | December 3, 2026 | Not listed | Same assistance listing 93.839 as 1 award here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.839 | December 4, 2026 | Not listed | Same assistance listing 93.839 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.839 | January 5, 2027 | Not listed | Same assistance listing 93.839 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.839 | January 5, 2027 | Not listed | Same assistance listing 93.839 as 1 award here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.839 | January 7, 2027 | $375,000 | Same assistance listing 93.839 as 1 award here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.839 | January 7, 2027 | Not listed | Same assistance listing 93.839 as 1 award here |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | RFA-NS-25-023 | NIH | 93.847 | January 15, 2027 | $350,000 | Same assistance listing 93.847 as 1 award here |
| Diabetes Research Centers (P30 Clinical Trial Optional) | RFA-DK-26-310 | NIH | 93.847 | January 27, 2027 | $1 million | Same assistance listing 93.847 as 1 award here |
| NIDDK Multi-Purpose Resource-Related, Multi-Component Research Services Centers Cooperative Agreement (U2C - Clinical Trial Optional) | RFA-DK-28-114 | NIH | 93.847 | January 28, 2027 | Not listed | Same assistance listing 93.847 as 1 award here |
| KUH P30 Resource Core Center (P30 Clinical Trial Not Allowed) | RFA-DK-28-312 | NIH | 93.847 | January 30, 2027 | Not listed | Same assistance listing 93.847 as 1 award here |
| KUH U24 Center Coordinating Hub (U24 Clinical Trial Not Allowed) | RFA-DK-28-313 | NIH | 93.847 | January 30, 2027 | Not listed | Same assistance listing 93.847 as 1 award here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) | PAR-25-025 | NIH | 93.839 | February 3, 2027 | $1.5 million | Same assistance listing 93.839 as 1 award here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) | PAR-25-026 | NIH | 93.839 | February 3, 2027 | Not listed | Same assistance listing 93.839 as 1 award here |
| Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional) | RFA-DK-27-119 | NIH | 93.847 | February 10, 2027 | $750,000 | Same assistance listing 93.847 as 1 award here |
| Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed) | RFA-DK-28-116 | NIH | 93.847 | February 10, 2027 | Not listed | Same assistance listing 93.847 as 1 award here |
Topics of its NIH awards
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.